Unusual concurrent presentation of a double hit (MYC/BCL2) and follicular lymphoma in a young patient; case report and review of key recent developments in double-hit lymphomas

被引:0
|
作者
Malhotra, Saurabh [1 ]
Levy, Norman B. [1 ]
Kaur, Prabhjot [1 ]
机构
[1] Dartmouth Hitchock Med Ctr, Dept Pathol, Lebanon, NH 03756 USA
关键词
Lymphoma; MYC/BCL2; Double-hit lymphomas; Diffuse large B cell lymphomas; B-CELL LYMPHOMA; BURKITT-LYMPHOMA; FEATURES; REARRANGEMENTS; T(14/18); PROGNOSIS; NEOPLASMS;
D O I
10.1007/s12308-013-0192-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Double-hit lymphomas, usually refer to the MYC/BCL2 lymphomas, and are characterized by MYC 8q rearrangement and BCL2-IgH translocation in the same cells. They mainly comprise of a subset of the new entity "B cell lymphomas unclassifiable with features intermediate between diffuse large B cell lymphomas (DLBCL) and Burkitt lymphoma" included in the World Health Organization 2008 classification. In addition, they also include a small subset of other DLBCL. They have been reported to have worse prognosis than either Burkitt or DLBCL, with which they share overlapping morphological and immunophenotypical features. These cases usually present de novo and have been reported in the older age group (Snuderl et al. in Am J Surg Pathol 34(3): 327-340, 2010; Le Gouill et al. in Haematologica 92(10): 1335-1342, 2007; Macpherson et al. in J Clin Oncol 17(5): 1558-1567, 1999; Johnson et al. in Blood 114(11): 22732279, 2009; Bertrand et al. in Leuk Off J Leuk Soc Am Leuk Res Fund UK 21(3): 515-523, 2007). Here, we describe an unusual simultaneous presentation of MYC/BCL2 double-hit lymphoma with low-grade follicular lymphoma, occurring at two different sites, in a young patient. This has not been reported to the best of our knowledge.
引用
收藏
页码:33 / 37
页数:5
相关论文
共 50 条
  • [21] Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors
    Weiping Li
    Shiv K. Gupta
    Weiguo Han
    Ryan A. Kundson
    Sara Nelson
    Darlene Knutson
    Patricia T. Greipp
    Sherine F. Elsawa
    Eduardo M. Sotomayor
    Mamta Gupta
    Journal of Hematology & Oncology, 12
  • [22] Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors
    Li, Weiping
    Gupta, Shiv K.
    Han, Weiguo
    Kundson, Ryan A.
    Nelson, Sara
    Knutson, Darlene
    Greipp, Patricia T.
    Elsawa, Sherine F.
    Sotomayor, Eduardo M.
    Gupta, Mamta
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)
  • [23] Double-Hit and Triple-Hit Follicular Lymphoma Case Series and Review of 40 Cases
    Ziemba, Jessica B.
    Wolf, Zena
    Weinstock, Matthew
    Asakrah, Saja
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 153 (05) : 672 - 685
  • [24] Double-hit or dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas
    Menguy, Sarah
    Frison, Eric
    Prochazkova-Carlotti, Martina
    Dalle, Stephane
    Dereure, Olivier
    Boulinguez, Serge
    Dalac, Sophie
    Machet, Laurent
    Ram-Wolff, Caroline
    Verneuil, Laurence
    Gros, Audrey
    Vergier, Beatrice
    Beylot-Barry, Marie
    Merlio, Jean-Philippe
    Pham-Ledard, Anne
    MODERN PATHOLOGY, 2018, 31 (08) : 1332 - 1342
  • [25] Double-hit and dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas
    Menguy, Sarah
    Frison, Eric
    Prochazkova-Carlotti, Martina
    Dalle, Stephane
    Dereure, Olivier
    Boulinguez, Serge
    Dalac, Sophie
    Machet, Laurent
    Ram-Wolff, Caroline
    Verneuil, Laurence
    Gros, Audrey
    Vergier, Beatrice
    Beylot-Barry, Marie
    Merlio, Jean-Philippe
    Pham-Ledard, Anne
    EUROPEAN JOURNAL OF CANCER, 2019, 119 : S20 - S20
  • [26] Concurrent inhibition of MYC and BCL2 is a potentially effective treatment strategy for double hit and triple hit B-cell lymphomas
    Cinar, Munevver
    Rosenfelt, Fred
    Rokhsar, Sepehr
    Lopategui, Jean
    Pillai, Raju
    Cervania, Melissa
    Pao, Andy
    Cinar, Bekir
    Alkan, Serhan
    LEUKEMIA RESEARCH, 2015, 39 (07) : 730 - 738
  • [27] Double-Hit Lymphoma (MYC and BCL6) with Involvement of Skull and Adnexal Lesions: A Case Report and a Review of the Literature
    Minhas, Hamza
    Abdelmalek, Cherif
    Khan, Marium
    O'Donnell, James E.
    Gotlieb, Vladimir
    Wang, Jen Chin
    AMERICAN JOURNAL OF CASE REPORTS, 2018, 19 : 1035 - 1041
  • [28] Primary Cutaneous Diffuse Large B-Cell Lymphoma With a MYC-IGH Rearrangement and Gain of BCL2: Expanding the Spectrum of MYC/BCL2 Double-Hit Lymphomas
    Testo, Natalia
    Olson, Luke C.
    Subramaniyam, Shivakumar
    Hanson, Ty
    Magro, Cynthia M.
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2016, 38 (10) : 769 - 774
  • [29] Therapeutic synergy between tigecycline and venetoclax in a preclinical model of MYC/BCL2 double-hit lymphoma.
    Rava, Micol
    D'andrea, Aleco
    Nicoli, Paola
    Doni, Mirko
    Amati, Bruno
    CLINICAL CANCER RESEARCH, 2017, 23 (24) : 28 - 28
  • [30] Extranodal presentation of a MYC/BCL6 double-hit lymphoma with 11q aberration in an older patient
    Lefebvre, Christine
    Szymanski, Gautier
    BLOOD, 2023, 141 (09) : 1093 - 1093